bioRxiv Science⌕ Search

Biology subjects

Hernandez, B. S.

Publications and source records attributed to Hernandez, B. S..

2 recordsLinked to original sources

A framework for deriving analytic long-term behavior of biochemical reaction networks

The long-term behaviors of biochemical systems are described by their steady states. Deriving these states directly for complex networks arising from real-world applications, however, is often challenging. Recent work has consequently focused on network-based approaches. Specifically, biochemical reaction networks are transformed into weakly reversible and deficiency zero networks, which allows the derivation of their analytic steady states. Identifying this transformation, however, can be challenging for large and complex networks. In this paper, we address this difficulty by breaking the complex network into smaller independent subnetworks and then transforming the subnetworks to derive the analytic steady states of each subnetwork. We show that stitching these solutions together leads to the the analytic steady states of the original network. To facilitate this process, we develop a user-friendly and publicly available package, COMPILES (COMPutIng anaLytic stEady States). With COMPILES, we can easily test the presence of bistability of a CRISPRi toggle switch model, which was previously investigated via tremendous number of numerical simulations and within a limited range of parameters. Furthermore, COMPILES can be used to identify absolute concentration robustness (ACR), the property of a system that maintains the concentration of particular species at a steady state regardless of any initial concentrations. Specifically, our approach completely identifies all the species with and without ACR in a complex insulin model. Our method provides an effective approach to analyzing and understanding complex biochemical systems. Author summarySteady states describe the long-term behaviors of biochemical systems, which are typically based on ordinary differential equations. To derive a steady state analytically, significant attention has been given in recent years to network-based approaches. While this approach allows a steady state to be derived as long as a network has a special structure, complex and large networks rarely have this structural property. We address this difficulty by breaking the network into smaller and more manageable independent subnetworks, and then use the network-based approach to derive the analytic steady state of each subnetwork. Stitching these solutions together allows us to derive the analytic steady state of the original network. To facilitate this process, we develop a user-friendly and publicly available package, COMPILES. COMPILES identifies critical biochemical properties such as the presence of bistability in a genetic toggle switch model and absolute concentration robustness in a complex insulin signaling pathway model.

systems biology↗

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

Cancer patients with advanced disease exhaust available clinical regimens and lack actionable genomic medicine results, leaving a large patient population without effective treatments options when their disease inevitably progresses. To address the unmet clinical need for evidence-based therapy assignment when standard clinical approaches have failed, we have developed a probabilistic computational modeling approach which integrates sequencing data with functional assay data to develop patient-specific combination cancer treatments. This computational modeling approach addresses three major challenges in personalized cancer therapy, which we validate across multiple species via computationally-designed personalized synergistic drug combination predictions, identification of unifying therapeutic targets to overcome intra-tumor heterogeneity, and mitigation of cancer cell resistance and rewiring mechanisms. These proof-of-concept studies support the use of an integrative functional approach to personalized combination therapy prediction for the population of high-risk cancer patients lacking viable clinical options and without actionable DNA sequencing-based therapy.

bioinformatics↗